ION Exchange (India)

Ion Exchange reported a muted Q4 FY26 with consolidated revenue of INR 863.3 croreCurrent reported value: INR 863.3 crore. No comparable prior figure is available in the source record. (+3Current 3 crore vs previous available quarter 6 crore.% YoY) and EBITDA margin of 2.31%Current reported value: 2.31%. No comparable prior figure is available in the source record., impacted by West Asia crisis disruptions and legacy project drags. Engineering segment revenue was flat at INR 553.9 crore, with order book at INR 2,643 croreCurrent INR 2,643 crore. Reported change: +40% YoY. (+40% YoY inflow). Chemical segment grew 3% but margins fell ~10pp due to Roha plant costs and raw material inflation. Consumer products grew 34% YoYCurrent 34% YoY. Reported change: +34% YoY. to INR 104.7 crore, with losses narrowing. Management highlighted the Mann+Hummel membrane technology partnership and WQA certification for Roha as key growth levers. Guidance remains cautious; no specific margin or revenue targets given. Key risk: continued West Asia crisis impacting logistics and input costs, delaying recovery in chemical and engineering margins.